MEET OUR DEDICATED MEMBERS OF THE BOARD OF DIRECTORS

Neal Davies
Neal DaviesPresident
Neal is a researcher, administrator, teacher, pharmacist and pharmaceutical scientist. Internationally renowned in drug investigations from discovery to patient recovery. Neal is currently the President of CSPS while also undertaking his duties with University of Alberta’s Faculty of Pharmacy and Pharmaceutical Sciences.
Christine Allen
Christine AllenPast President
Christine is Vice President, Ecosystem Development at adMare BioInnovations. Christine oversees adMare’s existing and future Innovation Centres as well as the adMare Academy to ensure that Canada has the highly skilled workforce to drive the life sciences sector forward.
Michael Doschak
Michael DoschakTreasurer
Michael is a Professor and the Assistant Dean (International) with the Faculty of Pharmacy & Pharmaceutical Sciences at the University of Alberta. He also serves as an Adjunct Associate Professor with the Department of Biomedical Engineering as well as with the Department of Orthodontics, Faculty of Medicine and Dentistry.
Risini Weeratna
Risini WeeratnaSecretary
Risini Weeratna is a Senior Research Officer and the Team Lead for Cancer Immunology at the National Research Council of Canada (NRC).
Fakhreddin (Mo) Jamali
Fakhreddin (Mo) JamaliDirector and Founder
Fakhreddin (Mo) is a Professor Emeritus, Faculty of Pharmacy & Pharmaceutical Sciences, University of Alberta. He is the founding President of CSPS and the Editor-in-Chief of the Journal of Pharmacy and Pharmaceutical Sciences, the first open access, fully electronic peer-reviewed journal in the field.
Lesia Babiak
Lesia BabiakDirector
Lesia is the head of Johnson & Johnson’s Government Affairs & Policy for Canada. In her role she is responsible for overseeing J&J Canada’s government strategy, relationships, and interactions, on behalf of the six J&J businesses in Canada. Lesia also chairs the J&J Canada’s Government Affairs Council.
Ildiko Badea
Ildiko BadeaDirector
Ildiko is a Professor of Pharmacy in the College of Pharmacy and Nutrition at the University of Saskatchewan, and a member of the Drug Discovery and Development Research Group. She teaches pharmaceutics and is co-chair of the University of Saskatchewan Biomedical Research Ethics Board.
Ron Boch
Ron BochDirector
Ron is the Vice President, Biotechnology and Industry Affairs with lead responsibility for BIOTECanada’s policy development reflecting the diverse nature of Canada’s health, industrial and agricultural biotechnology sectors.
Jack Bufton
Jack BuftonTrainee Representative
Growing up, Jack had a passion for chemistry and broad interest in most things science. He immigrated to Canada in 2015 and completed a bachelors specializing in Pharmaceutical Chemistry at the University of Toronto (U of T). Jack is currently in his third year of PhD studies working with Dr. Christine Allen at U of T.
Abby Collier
Abby CollierDirector
A member of the Faculty of Pharmaceutical Sciences at UBC since 2013, Dr. Collier is professor of Drug Metabolism and Pharmacokinetics, teaches pharmacology to undergraduate, graduate, pharmacy and medical students, maintains an active and well-funded research lab and directs the new undergraduate BPSc degree program.
Kayla Kitselman
Kayla KitselmanDirector
Kayla completed her BSc in Biochemistry at Memorial University in 2018. After which Kayla worked as a lab demonstrator for her current supervisor Dr. Noriko Daneshtalab. Currently, Kayla is pursuing her PhD in Biomedical Sciences focusing on Cardiovascular and Renal Sciences, which she aims to complete in 2024.
Catherine Lau
Catherine LauDirector
Recently retired, Catherine was previously VP Regulatory Affairs and Quality at Janssen Canada (a J&J company). Catherine was a graduate of Yale University with a PhD in Molecular Biology and Biochemistry and a post-doctoral fellow of Princess Margaret Hospital focusing on cancer research.
Co Pham
Co PhamDirector
Co is the Executive Director of the Centre for Regulatory Excellence, Statistics and Trials in the Biologics and Radiopharmaceutical Drugs Directorate at Health Canada. Previously, he was the Associate Director, Office of Clinical Trials, Special Access Program, Therapeutic Products Directorate.
Amyn Sayani
Amyn SayaniDirector
Amyn Sayani is currently the Director, Medical Evidence at AstraZeneca Canada, where he is accountable for all real-world evidence, outcomes research studies, and externally sponsored research across multiple therapy areas.